RxDoctor Payments Data

Vasantha Samala, MD

Critical Care Medicine · Oak Lawn, ILNPI 1053430033

Payments from drug & device makers

$2,758in general payments, 2019–2025

Across 136 payments — averaging $20.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$595
  • Boehringer Ingelheim$354
  • AstraZeneca$311
  • Grifols USA, LLC$235
  • Jazz Pharmaceuticals Inc.$201
  • Genentech USA, Inc.$153
  • plus $910 from 22 others

What the payments were for

  • Food & beverage$2,71899%
  • Education$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,758 in reported general payments places this provider in the 75th percentile of 281 critical care medicine providers in Illinois.

See all critical care medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$199,715
Medicare patients
750
Services billed
1,553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter112$91,648
Breo ElliptaFluticasone/Vilanterol30$19,207
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$16,668
Stiolto RespimatTiotropium Br/Olodaterol Hcl26$14,749
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr32$14,449
Spiriva HandihalerTiotropium Bromide16$14,264
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate24$6,446
SymbicortBudesonide/Formoterol Fumarate15$6,428
Pulmicort FlexhalerBudesonide12$3,167
Ventolin HfaAlbuterol Sulfate33$2,361
Albuterol Sulfate HfaAlbuterol Sulfate54$1,481
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,162
Prednisone60$387
Azithromycin29$298
Montelukast Sodium23$252

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$595$125,304174 claims
AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler$311$26,26353 claims
Boehringer IngelheimStiolto Respimat$354$14,74926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 281 critical care medicine providers in Illinois.

Other critical care medicine in Oak Lawn

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →